• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSZ2300044 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2023-10-09 view
JYSZ2300043 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2023-10-09 view
JYSZ2300042 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2023-10-09 view
JYSZ2300045 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2023-10-09 view
JYSB1700214 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2018-12-25 view
JYSB2000323 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2020-06-29 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2020-07-01 view
JXSL0900003 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Import Drug Application 2009-02-18 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2009-12-29 view
JYSB1400044 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2014-03-18 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2014-08-27 view
JYSZ1900022 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JXSS0900004 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Import Drug Application 2009-02-06 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2010-03-11 view
JYSB2100068 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2021-03-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH In Review 2021-03-10 view
JYSB1300246 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2013-10-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2015-01-22 view
JYSB2000322 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2020-06-29 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2020-07-01 view
JXSL0900004 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Import Drug Application 2009-02-18 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2009-12-29 view
JYSB1400046 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2014-03-18 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2014-08-27 view
JYSZ1900020 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JXSS0900002 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Import Drug Application 2009-02-06 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2010-03-11 view
JYSB2100067 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2021-03-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH In Review 2021-03-10 view
JYSB1300245 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2013-10-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2015-01-22 view
JYSB1700215 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-04-25 view